In the RA subjects, TLR10 expression significantly increased with disease activity in both the CD19+CD27+ subset and the CD19+CD27− subset (P = 0.038 and P = 0.001, respectively) (Table 2 and Figure 3(b)). The gene discussed is TLR10; the disease is rheumatoid arthritis.